AU2002237195A1 - Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus - Google Patents

Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus

Info

Publication number: AU2002237195A1
Authority: AU; Australia
Prior art keywords: immunodeficiency virus; human immunodeficiency; chimeric proteins; recombinant poxvirus; poxvirus
Prior art date: 2001-02-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002237195A

Other versions

AU2002237195B2 (en

Inventor

Carlos A. Duarte Cano

Enrique Iglesias Perez

Dania M. Vazquez Blomquist

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Centro de Ingenieria Genetica y Biotecnologia CIGB

Original Assignee

Centro de Ingenieria Genetica y Biotecnologia CIGB

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-28

Filing date

2002-02-22

Publication date

2003-03-06

2001-02-28 Priority claimed from CU20010057A external-priority patent/CU23235A1/en

2002-02-22 Application filed by Centro de Ingenieria Genetica y Biotecnologia CIGB filed Critical Centro de Ingenieria Genetica y Biotecnologia CIGB

2003-03-06 Publication of AU2002237195A1 publication Critical patent/AU2002237195A1/en

2007-01-04 Application granted granted Critical

2007-01-04 Publication of AU2002237195B2 publication Critical patent/AU2002237195B2/en

2022-02-22 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
CU57/2001		2001-02-28
CU20010057A CU23235A1 (en)	2001-02-28	2001-02-28	RECOMBINANT POXVIRUS FOR CHEMICAL PROTEINS OF THE HUMAN IMMUNODEFICIENCY VIRUS AND ITS APPLICATION IN THERAPEUTICS AND AIDS PREVENTION
PCT/CU2002/000001 WO2002068654A2 (en)	2001-02-28	2002-02-22	Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus

Publications (2)

Publication Number	Publication Date
AU2002237195A1 true AU2002237195A1 (en)	2003-03-06
AU2002237195B2 AU2002237195B2 (en)	2007-01-04

Family

ID=40091626

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002237195A Ceased AU2002237195B2 (en)	2001-02-28	2002-02-22	Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus

Country Status (16)

Country	Link
US (2)	US7318927B2 (en)
EP (1)	EP1371730B1 (en)
JP (1)	JP4125128B2 (en)
KR (1)	KR100920141B1 (en)
CN (1)	CN1526018B (en)
AR (1)	AR032871A1 (en)
AT (1)	ATE435916T1 (en)
AU (1)	AU2002237195B2 (en)
BR (2)	BR0206823A (en)
CA (1)	CA2430702C (en)
CU (1)	CU23235A1 (en)
DE (1)	DE60232862D1 (en)
ES (1)	ES2329768T3 (en)
RU (1)	RU2302461C2 (en)
WO (1)	WO2002068654A2 (en)
ZA (1)	ZA200304387B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9711957D0 (en)	1997-06-09	1997-08-06	Isis Innovation	Methods and reagents for vaccination
GB0118532D0 (en)	2001-07-30	2001-09-19	Isis Innovation	Materials and methods relating to improved vaccination strategies
CN101024842A (en)	2001-11-07	2007-08-29	曼康公司	Expression vectors encoding epitopes of target-associated antigens and its design method
EP1450854A2 (en)	2001-11-30	2004-09-01	Isis Innovation Limited	Vaccine
GB0225788D0 (en)	2002-11-05	2002-12-11	Glaxo Group Ltd	Vaccine
GB0225786D0 (en) *	2002-11-05	2002-12-11	Glaxo Group Ltd	Vaccine
WO2005048957A2 (en) *	2003-02-20	2005-06-02	Therion Biologics Corporation	Novel insertion sites in pox vectors
GB0417494D0 (en) *	2004-08-05	2004-09-08	Glaxosmithkline Biolog Sa	Vaccine
RU2324738C2 (en) *	2006-06-16	2008-05-20	Федеральное государственное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФГУН ГНЦ ВБ "Вектор" Роспотребнадзора)	GENETIC CONSTRUCTION ON BASIS OF VECTOR PLASMID pEGFP-N1 PRODUCING siPHK-INHIBITORS OF REPRODUCTION OF THE HUMAN IMMUNE DEFICIENCY VIRUS OF THE 1 TYPE (ITS VARIANTS)
US20080124355A1 (en)	2006-09-22	2008-05-29	David Gordon Bermudes	Live bacterial vaccines for viral infection prophylaxis or treatment
EP2620446A1 (en)	2012-01-27	2013-07-31	Laboratorios Del Dr. Esteve, S.A.	Immunogens for HIV vaccination
FR2987836A1 (en) *	2012-03-09	2013-09-13	Biomerieux Sa	INTERFERENCE PEPTIDES AND METHOD FOR DETECTING MICROORGANISMS
ES2805795T3 (en) *	2012-09-28	2021-02-15	Ellis Kline	Glycosidase regimen for the treatment of infectious diseases
US10676723B2 (en)	2015-05-11	2020-06-09	David Gordon Bermudes	Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en)	2016-12-07	2021-11-23	David Gordon Bermudes	Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en)	2016-12-07	2021-09-28	David Gordon Bermudes	Chimeric protein toxins for expression by therapeutic bacteria
WO2021003348A1 (en) *	2019-07-02	2021-01-07	Gritstone Oncology, Inc.	Hiv antigens and mhc complexes
EP4058058A1 (en)	2019-11-14	2022-09-21	Aelix Therapeutics S.L.	Dosage regimens for vaccines
CN112852749A (en) *	2021-03-27	2021-05-28	哈尔滨元亨生物药业有限公司	Hybridoma cell strain C68 capable of efficiently secreting canine parvovirus monoclonal antibody and production method thereof by using bioreactor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5505941A (en)	1981-12-24	1996-04-09	Health Research, Inc.	Recombinant avipox virus and method to induce an immune response
US5174993A (en)	1981-12-24	1992-12-29	Health Research Inc.	Recombinant avipox virus and immunological use thereof
GB8918200D0 (en) *	1989-08-09	1989-09-20	Medical Res Council	The peptide fragments of hiv
US7255862B1 (en) *	1996-11-14	2007-08-14	Connaught Technology Corporation	ALVAC/FIV constructs

2001
- 2001-02-28 CU CU20010057A patent/CU23235A1/en unknown
2002
- 2002-02-22 US US10/469,256 patent/US7318927B2/en not_active Expired - Fee Related
- 2002-02-22 EP EP02703488A patent/EP1371730B1/en not_active Expired - Lifetime
- 2002-02-22 AT AT02703488T patent/ATE435916T1/en not_active IP Right Cessation
- 2002-02-22 RU RU2003128991/13A patent/RU2302461C2/en not_active IP Right Cessation
- 2002-02-22 BR BR0206823-0A patent/BR0206823A/en not_active IP Right Cessation
- 2002-02-22 CA CA2430702A patent/CA2430702C/en not_active Expired - Fee Related
- 2002-02-22 WO PCT/CU2002/000001 patent/WO2002068654A2/en not_active Ceased
- 2002-02-22 AU AU2002237195A patent/AU2002237195B2/en not_active Ceased
- 2002-02-22 DE DE60232862T patent/DE60232862D1/en not_active Expired - Lifetime
- 2002-02-22 ES ES02703488T patent/ES2329768T3/en not_active Expired - Lifetime
- 2002-02-22 CN CN028034139A patent/CN1526018B/en not_active Expired - Fee Related
- 2002-02-22 BR BRPI0206823-0A patent/BRPI0206823B1/en unknown
- 2002-02-22 JP JP2002568748A patent/JP4125128B2/en not_active Expired - Fee Related
- 2002-02-22 KR KR1020037009273A patent/KR100920141B1/en not_active Expired - Fee Related
- 2002-02-27 AR ARP020100686A patent/AR032871A1/en not_active Application Discontinuation
2003
- 2003-06-04 ZA ZA200304387A patent/ZA200304387B/en unknown
2006
- 2006-07-14 US US11/486,535 patent/US20080280354A1/en not_active Abandoned

Similar Documents

Publication	Publication Date	Title
AU2002237195A1 (en)	2003-03-06	Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
AU2002320013A1 (en)	2002-11-18	Human secreted proteins
AU2002321999A1 (en)	2002-12-16	Human secreted proteins
DE60232862D1 (en)	2009-08-20	RECOMBINANT POX VIRUS FOR CHIMERIC PROTEINS OF THE HUMAN IMMUNE WEAK VIRUS
AU2003201727A1 (en)	2003-07-24	Recombinant protein expression
AU2002331599A1 (en)	2003-03-03	Epitopes of human immunodeficiency virus-1
AU2002300166A1 (en)	2003-06-12	Process for the Preparation of Peptides
AU2002233424A1 (en)	2003-02-06	Peptides having affinity for the GP120 viral protein and use thereof
AU2002305903A1 (en)	2002-12-09	Carbohydrate-associated proteins
AU2002322082A1 (en)	2003-01-02	Pharmaceutical composition for the treatment of viral infection
AU2002311620A1 (en)	2003-01-21	Methods of making and using expression constructs for the expression of recombinant proteins
AU2002342858A1 (en)	2002-11-25	Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus
AU2002346056A1 (en)	2003-01-29	Viral proteins capable of binding lar
AU2002316348A1 (en)	2003-01-08	Chimeric capsid proteins and uses thereof
AU2002357850A1 (en)	2003-06-30	Neurotransmission-associated proteins
AU2002308267A1 (en)	2002-10-03	Regulation of human icos v protein
AU2002254595A1 (en)	2002-10-28	Method for enhancing the translation and expression of recombinant proteins
AU2002257630A1 (en)	2002-09-24	Human mrp5-like protein
AU2002357873A1 (en)	2003-07-15	Carbohydrate-associated proteins
AU2003276159A1 (en)	2004-05-13	Immunisation against components of the human immunodeficiency virus (hiv)
AU2002365889A1 (en)	2003-06-17	Regulated expression of recombinant dna
AU2002306943A1 (en)	2002-10-15	Reducing the immunogenicity of fusion proteins
AU2002326909A1 (en)	2003-04-01	Neurotransmission-associated proteins
AU2002308997A1 (en)	2002-12-16	Protein preparation
AU2002308251A1 (en)	2002-09-24	Human prenylcysteine lyase-like protein